A controversial question over the past few years concerns who should deal with thyroid gland swellings. Thyroid surgery was for a long time in the realm of the 'general surgeon' but has moved to the remit of the specialist 'endocrine surgeon'. This false demarcation is now challenged by the head and neck surgeons, for whom the thyroid gland is familiar territory. The book therefore contains a comprehensive detailed chapter on tumours of the thyroid and another on the parathyroid gland. These chapters will be of interest and value to all surgeons dealing with these tumours. I like the way the book deals with clinical controversies. One issue in which I take a particular interest is the management of early laryngeal carcinoma and carcinoma-in-situ. Rather than provide didactic information, it offers a balanced text and numerous tables (highlighted in purple) displaying the results of treatments in various hands. This pattern of tables, summarizing published work, not only affords the relevant factual information; it provides an excellent stimulus to thought. Also, along with the clinical images, coloured 3-D diagrams (an art-form in themselves) allow the authors to avoid excessive detail in the text.
As well as serving as a superb reference work for head and neck surgeons and clinical oncologists, Principles and Practice of Head and Neck Oncology will be of value to other participants in the multidisciplinary team-ENT, maxillofacial, plastic and endocrine surgeons, for instance. Trainees in these specialties should also read it, to keep abreast of this advancing clinical discipline.
Andrew C Swift
University Hospital, Aintree, UK An admittedly unscientific survey of fellow district general hospital consultant haematologists has confirmed my impression that the subject about which we receive the most requests for an opinion is, by some distance, anticoagulation in all its guises. These inquiries emanate from clinical teams from the full range of specialties, general practice and, increasingly, nurse-led preadmission surgical clinics. A worrying lack of understanding of the basic principles and practice of antithrombotic therapy is regularly conveyed, often by senior clinicians, so there is no doubt that the publication of this monograph, a compilation of reviews originally published in the BMJ's popular ABC of . . . series is timely.
ABC of Antithrombotic Therapy
The editors and most of the authors work as academics and clinicians within the Haemostasis, Thrombosis and Vascular Biology Unit at the City Hospital in Birmingham. The unit's aim of synthesizing basic scientific research and clinical practice is certainly met in the book. I was particularly pleased to see only key and up-to-date references at the end of each chapter, thus sparing the non-specialist reader the quality-control tasks imposed by the endless lists in larger works.
The book starts with an overview of antithrombotic therapy, concentrating on the modes of action and potential bleeding risks of the increasing number of therapeutic agents. This is followed by very succinct chapters on the role of anticoagulant drugs in venous thromboembolism, cardiac arrhythmias and arterial disease. Finally, the increasing use of antithrombotic therapy in special circumstances, such as pregnancy, cancer and the thrombophilias, is dealt with. As one would expect from the publishing track record of the City Hospital unit, the chapters on antithrombotic therapy in atrial fibrillation are particularly informative. They outline a useful risk-stratified approach to deciding which subgroups of the very heterogeneous mass of patients with this arrhythmia should be treated, and give a clear explanation of the relative efficacy of warfarin and aspirin. As a non-cardiologist, I was also grateful for the lucid up-to-date overview of the respective merits of the various thrombolytic and antiplatelet agents now used in myocardial infarction and acute coronary syndromes.
I cannot unfortunately offer quite such fulsome praise to those chapters more closely related to my daily workload. Although it might appear churlish to criticize a necessarily concise monograph for its omissions, one would have expected more than a few paragraphs on the management of patients taking warfarin who undergo surgical or other invasive procedures. This clinical dilemma must now be faced several times per week in most general hospitals, and I feel that an opportunity was lost to publicize the growing body of evidence suggesting that, other than in high-risk patients (such as those with a metal mitral valve replacement or within three months of a venous thrombosis), surgery can safely be covered by prophylactic doses of either unfractionated or low-molecular-weight heparin. Full perioperative anticoagulation with intravenous heparin, and its associated major bleeding risk, can therefore be avoided in the majority.
With the use of low-molecular-weight heparins now so widespread in the treatment of venous thrombosis, I was also disappointed not to find any information on the reversal of over-anticoagulation with these preparations. As I have discovered from recent experience, this is much trickier than dealing with overdoses of intravenous unfractionated heparin, owing to the long half-life and subcutaneous mode of administration of the low-molecular-weight products. Over-anticoagulation with warfarin is also dealt with in a rather cursory fashion when we consider the large number of patients who now present with gastrointestinal or other bleeding as a consequence.
This well-illustrated book will undoubtedly succeed in bringing an up-to-date, easily digested, overview of antithrombotic therapy to a wide audience. I would be happy for all the preregistration house officers and the nurse practitioners in my Trust to read it from cover to cover. It does have shortcomings, however, several of which might have been avoided by the inclusion of (dare I say it?) a cardcarrying haematologist among the authors. Management of heart failure consumes as much as 2% of the total health budget. Several classes of drugs improve survival and quality of life, and their use crosses the boundaries of primary, secondary and tertiary care. The novel approach adopted by Willenheimer and Swedberg is to look at different types of patient and to tailor treatment accordingly.
After a chapter on general measures, recognized experts provide short accounts of management in special circumstances-in the elderly, women, pregnancy, chronic renal failure, coronary disease, valvular heart disease, and peripheral vascular disease. Grown-up congenital heart disease is not included, and as a cardiologist with a special interest in this enlarging group of patients I felt that it should have been. Three chapters have a different format and deserve special mention. One describes tailoring of neurohormonal modulating therapy. The recommended approach, which seems to me useful, is as follows. The patient with chronic heart failure is given a trial of angiotensin converting enzyme inhibitor, beta-blocker and spironolactone at the full doses used in trials. If this regimen is tolerated, then subsequently plasma brain natriuretic peptide measurement may be used to help decide whether to increase dosage or to add an angiotensin receptor blocker. If the side-effects prove intolerable, the recommendation is for multidrug therapy at less than full doses rather than a single drug in full dosage. This approach is not yet evidence-based, but it fits in with the recent concept of a low-dose polypill for cardiovascular disease prevention.
Another chapter looks at arrhythmias in heart failure. We are reminded that diuretics increase susceptibility to ventricular arrhythmias and that aldosterone antagonists are protective. In addition to antiarrhythmic medications the text includes implantable defibrillators, ventricular resynchronization with biventricular pacing and use of pacemakers to prevent attacks of atrial fibrillation or tachycardia. All may find an increasing role in management of heart failure in the future.
Finally, there is a chapter on depression in heart failure. I had not given this important subject enough thought. Studies suggest that 18% of patients have major depression and that this figure is even higher in those under 65 (24%). In addition, many others have subclinical depression. In one survey, only one in five patients who met criteria for major depression were prescribed an antidepressant drug. We need to recognize depression in patients with chronic heart failure and treat it effectively. Newer antidepressants, such as the selective serotonin reuptake inhibitors and the noradrenergic serotonergic enhancer mirtazapine, seem safe to use in such patients.
There is a lot of useful information in this book, which flows well despite the many authors. The chapters are short and can be dipped into when needed. I recommend it to any clinician who looks after patients with heart failure. Strange history, intriguing curiosities, unhappy lessons for would-be controllers of the cocaine trade and satisfaction for the armchair traveller await the reader of this handsomely produced paperback. Over the years, Professor Karch has written much about cocaine, its actions and its licit and illegal usage, and this new book extends his previous writings on the ways in which cocaine has been used and abused by various European governments for their own purposes. It presents six accounts of the earliest botanical studies, planting and trade in cocaine which illustrate the ability of the species to thrive in Java (now part of Indonesia) as well as in South America, how 19th century pharmacognostic confusion muddled the start of legal international trade in the plant and its alkaloid, and the
